Can chronic pain be "turned down"? The technology giving thousands of people their lives back

The weight of the invisible

For those who don't live with it, pain is just a word. But for those who endure it day after day, chronic pain is not a simple discomfort: it is an "invisible prison." According to data from the European Health Survey, between 17% and 40% of the adult population lives with this reality, a condition that deeply affects the emotional, family and work spheres.

Conventional treatments are often insufficient, leaving the patient trapped in a cycle of frustration and medication dependence. Neuromodulation, however, poses a question that changes the approach: what if, instead of trying to eliminate a physical cause that is sometimes unreachable, we could filter and modulate the signals the body sends to the brain?

A "pacemaker" for pain: the science of neurostimulation

Spinal cord stimulation consists of an implantable device, similar to a pacemaker, that uses gentle electrical impulses to interfere with pain signals before they reach the thalamus and the cerebral cortex.

Its scientific basis lies in the Gate Control Theory. By selectively activating the A-beta fibers —myelinated, larger in diameter and fast-conducting—, the device "closes the gate" to the harmful stimuli travelling along the slower C fibers. But this relief is not only electrical, it is also neurochemical: the stimulation acts by restoring GABA levels in the dorsal horn of the spinal cord and promoting the release of adenosine, thereby reducing neuropathic pain in a biological way.

Anatomically, precision is key to success. For example, to treat pain in the lower limbs, the tip of the electrode must be surgically placed between the T9 and T10 levels, so that the patient perceives a paresthesia —a pleasant tingling— that replaces the painful sensation.

This approach is different because it treats pain by modulating the signal in a targeted and reversible way, avoiding the systemic effects of medication and seeking to restore lost function.

The big advantage: trying before deciding

Unlike other definitive surgeries, spinal cord stimulation has a trial phase, which I consider the most critical step of the whole process. For 5 to 15 days, the patient uses temporary electrodes connected to an external stimulator to evaluate the system in their "real life."

From the standpoint of clinical honesty, a trial period that does not achieve the desired goals is also a useful result: it avoids subjecting the patient to an unnecessary permanent implant and allows the medical team to explore other therapeutic alternatives.

During this phase we use objective clinical tools to measure change. We assess improvement with the Visual Analog Scale (VAS) for pain intensity and the Oswestry Disability Index to measure functional impact. The patient should pay attention to:

It's not just the body: why the mind is key to success

The technology is powerful, but the device alone does not guarantee the outcome. The psychological protocol developed at reference centers such as Hospital La Fe emphasizes that a multidisciplinary assessment substantially raises the success rate of the implant —up to 92% in their experience—.

Chronic pain alters cognitive perception. Factors such as catastrophizing —an excessively negative appraisal— or an external locus of control —placing all responsibility on the device— can compromise the outcome. On the contrary, we seek to strengthen the patient's resilience (measured with scales such as the CD-RISC 10), that is, their capacity to adapt and respond positively to adversity. Identifying unrealistic expectations, such as seeking "zero pain," is vital to ensure that the patient is an active collaborator and not a passive subject of the treatment.

The "therapeutic partner": the power of shared experience

One of the most human innovations of this therapy is the figure of the partner or therapeutic collaborator: a patient who has already been successfully implanted and advises new candidates as an equal.

This exchange breaks down the barriers of technical information. In group sessions, the collaborator answers questions the doctor sometimes doesn't get to address: from aesthetic concerns about scars, to the everyday handling of the charger or dealing with initial technical difficulties. Hearing from someone who has regained their life humanizes the technology and reduces preoperative anxiety, allowing the new patient to make a decision based on trust and real knowledge.

Expectations vs. reality: what the system can and cannot do

My commitment is transparency. The goal is not an absolute cure, but function. These are the three points I always discuss with my patients before deciding:

A question for the road

Spinal cord stimulation is one of the clearest expressions of personalized medicine. It is a cost-efficient tool that not only seeks to relieve suffering, but can also reduce the burden on the health system by decreasing consultations and work-related disability. But beyond the data, its value lies in the quality of every minute regained.

If the success of this implant is measured by the activities the pain had taken away and that the patient can now resume, I close with the reflection that guides my clinical practice:

Frequently asked questions

The information in this article is educational and does not replace an individual medical assessment. The indication for spinal cord stimulation is evaluated case by case.